Viewing Study NCT06791460


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-03-09 @ 4:06 AM
Study NCT ID: NCT06791460
Status: RECRUITING
Last Update Posted: 2025-03-18
First Post: 2025-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer
Sponsor: Obstetrics & Gynecology Hospital of Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module